Meta-analysis finds intranasal esketamine boosts remission in MDD and TRD fast, but side effects and short trials leave long-term questions.
Nick Ratzloff, DO
Advertisement
Dr Ratzloff is a first-year psychiatry resident at Creighton University in Omaha, Nebraska.
Articles by Nick Ratzloff, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Top 10 Misleading Claims About Antidepressants
2
New Positive Data From Largest Real-World Study of Deep TMS in Patients With Comorbid PTSD and MDD
3
Tribalism in Psychiatry: On the Mind of John J. Miller, MD
4
Positive Phase 3 Data for Centanafadine to Treat Comorbid ADHD and Anxiety
5